Old Web
English
Sign In
Acemap
>
authorDetail
>
Z. Zimmerman
Z. Zimmerman
University of Miami
Medicine
Carboplatin
Stage III Non-Small Cell Lung Cancer
Phases of clinical research
Oncology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET
2020
European Journal of Cancer
David S. Hong
Lyudmila Bazhenova
B.C. Cho
S. Sen
M. Ponz Sarvise
Rebecca S. Heist
Z. Zimmerman
X Le
D. Xuan
Z. Junming
J. Jack Lee
Show All
Source
Cite
Save
Citations (2)
2493 : A Phase II Study of Concurrent Chemo-Radiation (CXRT) With Irinotecan and Carboplatin Followed by Consolidation Docetaxel for Stage III Non-Small Cell Lung Cancer (NSCLC): Initial Outcome and Toxicity Results
2006
International Journal of Radiation Oncology Biology Physics
Matthew C. Biagioli
Luis E. Raez
Cristiane Takita
Caio Rocha-Lima
E. Roman
Z. Zimmerman
M. Kar
N. Farfan
Arnold M. Markoe
Show All
Source
Cite
Save
Citations (0)
2493 : A Phase II Study of Concurrent Chemo-Radiation (CXRT) With Irinotecan and Carboplatin Followed by Consolidation Docetaxel for Stage III Non-Small Cell Lung Cancer (NSCLC): Initial Outcome and Toxicity Results
2006
International Journal of Radiation Oncology Biology Physics
Matthew C. Biagioli
Luis E. Raez
Cristiane Takita
Caio Rocha-Lima
E. Roman
Z. Zimmerman
M. Kar
N. Farfan
Arnold M. Markoe
Show All
Source
Cite
Save
Citations (0)
1